Back
EHRA Premium Access

A platform for assessing pro- and anti-arrhythmic effects of drugs based on isogenic human iPSC-derived cardiomyocytes

Session: Poster Session 1 - 43rd EWGCCE Meeting
Topic: Arrhythmias
Speaker: Doctor G. Campostrini (Leiden, NL)
Event: EHRA 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Giulia Campostrini

Leiden University Medical Center, Leiden (Netherlands (The))
1 follower

17 more presentations in this session

The hidden electrophysiological cardiotoxic effects of rofecoxib are prevented by ischaemic preconditioning

Speaker: Doctor Z. Husti (Szeged, HU)

Access
Abstract
Like
Thumbnail

A high-throughput system to reliably characterize normal human ventricular electrophysiology from living patients

Speaker: Doctor A. Olivan-Viguera (Zaragoza, ES)

Access
Abstract
Like
Thumbnail

Pros and cons of human iPSC cardiomyocytes in drug testing and disease modelling: insights from computational modelling

Speaker: Doctor J. Koivumaeki (Tampere, FI)

Access
Abstract
Like
Thumbnail

Advanced morpho-functional analysis on ventricular and atrial tissue reveals sarcomere energetic impairment in hcm patients

Speaker: Miss E. Lazzeri (Florence, IT)

Access
Abstract
Like
Thumbnail

Istaroxime improves diabetic diastolic dysfunction through SERCA stimulation

Access
Like
Thumbnail

Access the full session

Poster Session 1 - 43rd EWGCCE Meeting

Speakers: Doctor G. Campostrini, Doctor Z. Husti, Doctor A. Olivan-Viguera, Doctor J. Koivumaeki, Miss E. Lazzeri
Access
Like
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources